Skip to main content

Table 1 Samples, histology and presence of activating KRAS mutations

From: Presence of activating KRAS mutations correlates significantly with expression of tumour suppressor genes DCN and TPM1 in colorectal cancer

Number

T

N

KRAS status

1

3

0

wt

2

1

0

wt

3

2

0

wt

4

4

2

wt

5

3

2

wt

6

3

1

12G>S

7

3

2

13G>D

8

1

0

12G>S

9

3

1

13G>D

10

4

0

13G>D

11

3

1

wt

12

3

1

wt

13

3

0

12G>S

14

3

0

12G>S

15

3

0

13G>D

16

3

0

wt

  1. The table shows sample histological data and the presence of activating KRAS mutations. No activating KRAS mutations were found in corresponding normal tissue.
  2. T = tumour stage, N = nodal status, KRAS status – presence or absence of activating KRAS mutations.